SanBio Co Stock

SanBio Co Gross Margin

Gross Margin of SanBio Co (4592.T) as of Aug 5, 2026.

Gross Margin

0.00

Last updated:

Gross Margin of SanBio Co is 2026 0.00 . Gross Margin of SanBio Co was 2025 0.00 . It decreases by % lower compared to the previous year.

SanBio Co's gross margin stands at 98.2%, up from 0.0% several years earlier.

Access this data via the Eulerpool API

SanBio Co Stock analysis

What does SanBio Co do? SanBio Co Ltd is a leading bio-pharmaceutical company focused on the development of products for the treatment of serious neurological diseases. The company was founded in Japan in 2000 and has since become a multinational company with offices in the USA and Europe. Answer: SanBio Co Ltd is a bio-pharmaceutical company that specializes in developing products for the treatment of serious neurological diseases. It was founded in Japan in 2000 and has expanded to become a multinational company with offices in the USA and Europe. SanBio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SanBio Co stock

On Eulerpool you can find the complete historical development of Gross Margin SanBio Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's SanBio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — SanBio Co

All Key Metrics — SanBio Co